T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Ryanair
RYAAY
$30.7B
| $93.9M | 0.02% |
4,103,188
-155,507
| -4% | -$3.55M |
|
|
TW
652
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $93.9M | 0.02% |
900,452
+454,060
| +102% | +$49.6M |
|
653
Bankunited
BKU
$3.41B
| $93.5M | 0.02% |
2,793,210
-12,450
| -0.4% | -$413K |
|
|
PCL
654
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
| $93.3M | 0.02% |
2,069,295
+12,526
| +0.6% | +$545K |
|
655
Minerals Technologies
MTX
$2.26B
| $93M | 0.02% |
1,418,370
+137,850
| +11% | +$8.61M |
|
656
Strategic Education
STRA
$1.86B
| $92.9M | 0.02% |
1,769,655
+187,800
| +12% | +$9.5M |
|
657
Warner Bros
WBD
$69.6B
| $92.8M | 0.02% |
2,446,211
+1,663,939
| +213% | +$65.5M |
|
658
Tenet Healthcare
THC
$21.5B
| $92.5M | 0.02% |
1,969,660
-7,200
| -0.4% | -$325K |
|
659
Woodward
WWD
$21.2B
| $92.2M | 0.02% |
1,837,010
-372,115
| -17% | -$17M |
|
|
CHS
660
DELISTED
Chicos FAS, Inc.
CHS
| $91.9M | 0.02% |
5,421,020
-69,410
| -1% | -$1.11M |
|
661
Air Products & Chemicals
APD
$68B
| $91.9M | 0.02% |
772,714
-385,079
| -33% | -$43M |
|
|
ZQK
662
DELISTED
QUICKSILVER,INC.
ZQK
| $91.9M | 0.02% |
25,661,292
-843,465
| -3% | -$4.74M |
|
663
Prudential Financial
PRU
$43B
| $91.7M | 0.02% |
1,033,400
+6,400
| +0.6% | +$538K |
|
664
Commault Systems
CVLT
$6.26B
| $91.5M | 0.02% |
1,861,810
-359,065
| -16% | -$19.3M |
|
|
TUMI
665
DELISTED
TUMI HLDGS INC COM
TUMI
| $91.4M | 0.02% |
4,539,472
-2,161,547
| -32% | -$43.6M |
|
|
EFOR
666
Everforth Inc
EFOR
$1.37B
| $91.2M | 0.02% |
2,562,990
+1,800
| +0.1% | +$64.4K |
|
667
Diamondrock Hospitality Co
DRH
$2.51B
| $90.9M | 0.02% |
7,089,696
-236,820
| -3% | -$2.91M |
|
668
Banco Santander Chile
BSAC
$16.1B
| $90.5M | 0.02% |
3,420,116
-969,801
| -22% | -$24.2M |
|
669
Littelfuse
LFUS
$11.4B
| $90.3M | 0.02% |
971,580
-150
| -0% | -$13.7K |
|
670
Steris
STE
$23B
| $89.5M | 0.02% |
1,674,131
-51,080
| -3% | -$2.63M |
|
671
ESCO Technologies
ESE
$7.79B
| $89.5M | 0.02% |
2,583,820
+342,057
| +15% | +$11.7M |
|
|
GK
672
DELISTED
G&K Services Inc
GK
| $89.5M | 0.02% |
1,718,500
+4,500
| +0.3% | +$245K |
|
673
LCI Industries
LCII
$2.6B
| $89.4M | 0.02% |
1,786,990
-2,100
| -0.1% | -$105K |
|
674
Artisan Partners
APAM
$3.03B
| $89.2M | 0.02% |
1,574,260
+136,100
| +9% | +$7.79M |
|
675
Methode Electronics
MEI
$593M
| $88.9M | 0.02% |
2,326,580
+26,250
| +1% | +$803K |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.